Wayne Tsuji

4.9k total citations · 3 hit papers
26 papers, 3.7k citations indexed

About

Wayne Tsuji is a scholar working on Rheumatology, Hematology and Immunology. According to data from OpenAlex, Wayne Tsuji has authored 26 papers receiving a total of 3.7k indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Rheumatology, 6 papers in Hematology and 6 papers in Immunology. Recurrent topics in Wayne Tsuji's work include Rheumatoid Arthritis Research and Therapies (15 papers), Spondyloarthritis Studies and Treatments (8 papers) and Autoimmune and Inflammatory Disorders Research (6 papers). Wayne Tsuji is often cited by papers focused on Rheumatoid Arthritis Research and Therapies (15 papers), Spondyloarthritis Studies and Treatments (8 papers) and Autoimmune and Inflammatory Disorders Research (6 papers). Wayne Tsuji collaborates with scholars based in United States, Netherlands and Germany. Wayne Tsuji's co-authors include P A Ory, Alan Kivitz, Stanley Cohen, John T. Sharp, John C. Davis, Désirée van der Heijde, Nancy E. Lane, Philip J. Mease, Joel Rubenstein and Francis X. Burch and has published in prestigious journals such as The Journal of Immunology, Gastroenterology and British Journal of Pharmacology.

In The Last Decade

Wayne Tsuji

26 papers receiving 3.5k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Etanercept treatment of psoriatic arthritis: Safety, efficacy, and effect on disease progression

2004 697 citations Philip J. Mease, Alan Kivitz et al. Arthritis & Rheumatism profile →
Recombinant human tumor necrosis factor receptor (etanercept) for treating ankylosing spondylitis: A randomized, controlled trial

2003 583 citations John C. Davis, Désirée van der Heijde et al. Arthritis & Rheumatism profile →
Radiographic progression of ankylosing spondylitis after up to two years of treatment with etanercept

2008 408 citations D. van der Heijde, Robert Landewé et al. Arthritis & Rheumatism profile →

Peers

Countries citing papers authored by Wayne Tsuji

Since Specialization

Citations

This map shows the geographic impact of Wayne Tsuji's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wayne Tsuji with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wayne Tsuji more than expected).

Fields of papers citing papers by Wayne Tsuji

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Wayne Tsuji. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wayne Tsuji. The network helps show where Wayne Tsuji may publish in the future.

Co-authorship network of co-authors of Wayne Tsuji

This figure shows the co-authorship network connecting the top 25 collaborators of Wayne Tsuji. A scholar is included among the top collaborators of Wayne Tsuji based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Wayne Tsuji. Wayne Tsuji is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Brief Report: A Randomized, Double‐Blind, Parallel‐Group, Placebo‐Controlled, Multiple‐Dose Study to Evaluate AMG 557 in Patients With Systemic Lupus Erythematosus and Active Lupus Arthritis 2018 ·Arthritis & Rheumatology ·Laurence E. Cheng, Zahir Amoura, Benjamin C. Cheah, Falk Hiepe, Barbara Sullivan, Lei Zhou, Gregory E. Arnold, Wayne Tsuji, Joan T. Merrill, James Chung	52
2	Inducible T-cell co-stimulator ligand (ICOSL) blockade leads to selective inhibition of anti-KLH IgG responses in subjects with systemic lupus erythematosus 2016 ·Lupus Science & Medicine ·Barbara Sullivan, Wayne Tsuji, Alan Kivitz, Joanna Peng, Gregory E. Arnold, Michael Boedigheimer, (unknown), (unknown), Arunan Kaliyaperumal, (unknown), John Ferbas, James Chung	58
3	Safety, tolerability, pharmacokinetics, and efficacy of AMG 403, a human anti-nerve growth factor monoclonal antibody, in two phase I studies with healthy volunteers and knee osteoarthritis subjects 2015 ·Arthritis Research & Therapy ·Jason M. Gow, Wayne Tsuji, Gary J. Williams, Daniel T. Mytych, David Sciberras, (unknown), Tim Mant, John P. Gibbs	22
4	Treatment of systemic lupus erythematosus patients with the BAFF antagonist “peptibody” blisibimod (AMG 623/A-623): results from randomized, double-blind phase 1a and phase 1b trials 2015 ·Arthritis Research & Therapy ·William Stohl, Joan T. Merrill, R. John Looney, Jill P. Buyon, Daniel J. Wallace, Michael H. Weisman, Ellen M. Ginzler, Blaire Cooke, Donna Holloway, Arunan Kaliyaperumal, (unknown), (unknown), Erik Rasmussen, John Ferbas, (unknown), Wayne Tsuji, Debra Zack	47
5	Modeling the pharmacokinetic‐pharmacodynamic relationship of the monoclonal anti‐macaque‐IL‐15 antibody Hu714MuXHu in cynomolgus monkeys 2015 ·Pharmacology Research & Perspectives ·(unknown), Hong Li, Jim Xiao, Michelle Horner, Hervé Lebrec, Eric Butz, Arunan Kaliyaperumal, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Wayne Tsuji, Larry C. Wienkers, Kathleen Köck	1
6	Homeostasis of Human NK Cells Is Not IL-15 Dependent 2013 ·The Journal of Immunology ·Hervé Lebrec, Michelle Horner, Kevin Gorski, Wayne Tsuji, (unknown), (unknown), Gary Means, (unknown), Nianyu Li, Marc W. Retter, (unknown), Neha Patel, Padma Kumar Narayanan, Eric Butz	34
7	A Review of Current Animal Models of Osteoarthritis Pain 2011 ·Current Pharmaceutical Biotechnology ·Warren N. D’Souza, Gordon Ng, Bradley D. Youngblood, Wayne Tsuji, Sonya G. Lehto	17
8	OARSI-FDA initiative: defining the disease state of osteoarthritis 2011 ·Osteoarthritis and Cartilage ·Nancy E. Lane, K D Brandt, Gillian Hawker, Elena Peeva, E. Schreyer, Wayne Tsuji, Marc C. Hochberg	267
9	Magnetic Resonance Imaging in Rheumatoid Arthritis Clinical Trials: Emerging Patterns Based on Recent Experience 2011 ·The Journal of Rheumatology ·Charles Peterfy, P.J. Countryman, Annarita Gabriele, Tim Shaw, Andrew M. Anisfeld, Wayne Tsuji, Ewa Olech, Norman Gaylis, Philip G. Conaghan, Vibeke Strand, Julie C. DiCarlo	17
10	Patient-reported Outcomes in a Randomized Trial of Etanercept in Psoriatic Arthritis 2010 ·The Journal of Rheumatology ·Philip J. Mease, J. Michael Woolley, Amitabh Singh, Wayne Tsuji, M. Dunn, Chiun‐Fang Chiou	43
11	Denosumab‐mediated increase in hand bone mineral density associated with decreased progression of bone erosion in rheumatoid arthritis patients 2010 ·Arthritis Care & Research ·Atul Deodhar, Robin K. Dore, David R. Mandel, Joy Schechtman, William Shergy, Robert G. Trapp, P A Ory, Charles Peterfy, Thomas Fuerst, H. Wang, Lifen Zhou, Wayne Tsuji, Richard Newmark	96
12	Denosumab prevents metacarpal shaft cortical bone loss in patients with erosive rheumatoid arthritis 2010 ·Arthritis Care & Research ·John T. Sharp, Wayne Tsuji, P A Ory, (unknown), Huei Wang, Richard Newmark	49
13	Effects of denosumab on bone mineral density and bone turnover in patients with rheumatoid arthritis receiving concurrent glucocorticoids or bisphosphonates 2009 ·Annals of the Rheumatic Diseases ·Robin K. Dore, Stanley Cohen, Nancy E. Lane, William E. Palmer, William Shergy, Lifen Zhou, Hui Wang, Wayne Tsuji, Richard Newmark	138
14	Denosumab treatment effects on structural damage, bone mineral density, and bone turnover in rheumatoid arthritis: A twelve‐month, multicenter, randomized, double‐blind, placebo‐controlled, phase II clinical trial 2008 ·Arthritis & Rheumatism ·Stanley Cohen, Robin K. Dore, Nancy E. Lane, P A Ory, Charles Peterfy, John T. Sharp, Désirée van der Heijde, Lifen Zhou, Wayne Tsuji, Richard Newmark, (unknown)	435
15	Radiographic progression of ankylosing spondylitis after up to two years of treatment with etanercept breakdown → 2008 ·Arthritis & Rheumatism ·D. van der Heijde, Robert Landewé, Steven Einstein, P A Ory, Debby Vosse, L. Ni, (unknown), Wayne Tsuji, John C. Davis	408
16	Rapid and sustained improvement in health-related quality of life and utility for 72 weeks in patients with ankylosing spondylitis receiving etanercept. 2008 ·PubMed ·Annelies Boonen, Vaishali Patel, Shana Traina, (unknown), Andreas Maetzel, Wayne Tsuji	31
17	Bone erosions and bone marrow edema as defined by magnetic resonance imaging reflect true bone marrow inflammation in rheumatoid arthritis 2007 ·Arthritis & Rheumatism ·(unknown), (unknown), Beatrice Hanslik‐Schnabel, R. Dorotka, A. Wanivenhaus, F. Kainberger, Siegfried Trattnig, Roland Axmann, Wayne Tsuji, (unknown), Josef S Smolen, Georg Schett	209
18	Baseline factors that influence ASAS 20 response in patients with ankylosing spondylitis treated with etanercept. 2005 ·PubMed ·John C. Davis, Désirée van der Heijde, Maxime Dougados, Jürgen Braun, John J. Cush, Daniel O. Clegg, Robert D. Inman, (unknown), Wayne Tsuji	58
19	Etanercept treatment of psoriatic arthritis: Safety, efficacy, and effect on disease progression breakdown → 2004 ·Arthritis & Rheumatism ·Philip J. Mease, Alan Kivitz, Francis X. Burch, Evan Siegel, Stanley Cohen, P A Ory, David Salonen, Joel Rubenstein, John T. Sharp, Wayne Tsuji	697
20	Recombinant human tumor necrosis factor receptor (etanercept) for treating ankylosing spondylitis: A randomized, controlled trial breakdown → 2003 ·Arthritis & Rheumatism ·John C. Davis, Désirée van der Heijde, Jürgen Braun, Maxime Dougados, John J. Cush, Daniel O. Clegg, Alan Kivitz, Roy Fleischmann, Robert D. Inman, Wayne Tsuji, (unknown)	583

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact